Individuals with NODAP have worse glycaemic control [21], increased need for insulin therapy [21], higher incidence of pancreatic cancer [25], and higher hospitalisations and mortality than individuals with type 2 diabetes [26]. This evidence concerns the gene INS and type 2 diabetes mellitus.